Global Mesalazine Market Research Report 2020

Publisher Name :
Date: 22-Jan-2020
No. of pages: 116
Inquire Before Buying

The global Mesalazine market is valued at 130.3 million US$ in 2020 is expected to reach 174.3 million US$ by the end of 2026, growing at a CAGR of 4.2% during 2021-2026.

This report focuses on Mesalazine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Mesalazine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and India etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Mesalazine market is segmented into

- Purity = 97 %

- Purity = 98 %

- Purity = 99 %

- Purity=98% occupied the largest sales share of 60.32% in 2018, consumption volume was 1346.6 MT. Purity=99% growth fastest in the forecast period with a CAGR of 4.46% from 2019 to 2025.

Segment by Application

- Mesalazine Tablets

- Mesalazine Capsules

- Others

- In 2018, the consumption volume of Mesalazine Tablets was 1456.0 MT, accounting for 51.36% of global share. And it excepted to reach 1811.9 MT in 2025, with the CAGR of 3.41% from 2019 to 2025, slightly lower than global market growth.

Global Mesalazine Market: Regional Analysis

The Mesalazine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Mesalazine market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Mesalazine Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Mesalazine market include:

- Syntese A/S

- Divis Laboratories

- Cambrex Corporation

- Ipca Laboratories

- PharmaZell

- Lasa Loboratory

- Erregierre SpA

- Corden Pharma Bergamo

- CTX Lifescience

- Ishita Active Pharma Ingredients

- YC Biotech (Jiangsu)

- Xinxiang Tianfeng Fine Chemical

Global Mesalazine Market Research Report 2020

Table of Contents
1 Mesalazine Market Overview
1.1 Product Overview and Scope of Mesalazine
1.2 Mesalazine Segment by Type
1.2.1 Global Mesalazine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Purity = 97 %
1.2.3 Purity = 98 %
1.2.4 Purity = 99 %
1.3 Mesalazine Segment by Application
1.3.1 Mesalazine Sales Comparison by Application: 2020 VS 2026
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Global Mesalazine Market Size Estimates and Forecasts
1.4.1 Global Mesalazine Revenue 2015-2026
1.4.2 Global Mesalazine Sales 2015-2026
1.4.3 Mesalazine Market Size by Region: 2020 Versus 2026
2 Global Mesalazine Market Competition by Manufacturers
2.1 Global Mesalazine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Mesalazine Revenue Share by Manufacturers (2015-2020)
2.3 Global Mesalazine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Mesalazine Manufacturing Sites, Area Served, Product Type
2.5 Mesalazine Market Competitive Situation and Trends
2.5.1 Mesalazine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Mesalazine Players (Opinion Leaders)
3 Mesalazine Retrospective Market Scenario by Region
3.1 Global Mesalazine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Mesalazine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Mesalazine Market Facts & Figures by Country
3.3.1 North America Mesalazine Sales by Country
3.3.2 North America Mesalazine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Mesalazine Market Facts & Figures by Country
3.4.1 Europe Mesalazine Sales by Country
3.4.2 Europe Mesalazine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Mesalazine Market Facts & Figures by Region
3.5.1 Asia Pacific Mesalazine Sales by Region
3.5.2 Asia Pacific Mesalazine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Mesalazine Market Facts & Figures by Country
3.6.1 Latin America Mesalazine Sales by Country
3.6.2 Latin America Mesalazine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Mesalazine Market Facts & Figures by Country
3.7.1 Middle East and Africa Mesalazine Sales by Country
3.7.2 Middle East and Africa Mesalazine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Mesalazine Historic Market Analysis by Type
4.1 Global Mesalazine Sales Market Share by Type (2015-2020)
4.2 Global Mesalazine Revenue Market Share by Type (2015-2020)
4.3 Global Mesalazine Price Market Share by Type (2015-2020)
4.4 Global Mesalazine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Mesalazine Historic Market Analysis by Application
5.1 Global Mesalazine Sales Market Share by Application (2015-2020)
5.2 Global Mesalazine Revenue Market Share by Application (2015-2020)
5.3 Global Mesalazine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Mesalazine Business
6.1 Syntese A/S
6.1.1 Corporation Information
6.1.2 Syntese A/S Description, Business Overview and Total Revenue
6.1.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Syntese A/S Products Offered
6.1.5 Syntese A/S Recent Development
6.2 Divis Laboratories
6.2.1 Divis Laboratories Mesalazine Production Sites and Area Served
6.2.2 Divis Laboratories Description, Business Overview and Total Revenue
6.2.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Divis Laboratories Products Offered
6.2.5 Divis Laboratories Recent Development
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Mesalazine Production Sites and Area Served
6.3.2 Cambrex Corporation Description, Business Overview and Total Revenue
6.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Cambrex Corporation Products Offered
6.3.5 Cambrex Corporation Recent Development
6.4 Ipca Laboratories
6.4.1 Ipca Laboratories Mesalazine Production Sites and Area Served
6.4.2 Ipca Laboratories Description, Business Overview and Total Revenue
6.4.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ipca Laboratories Products Offered
6.4.5 Ipca Laboratories Recent Development
6.5 PharmaZell
6.5.1 PharmaZell Mesalazine Production Sites and Area Served
6.5.2 PharmaZell Description, Business Overview and Total Revenue
6.5.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 PharmaZell Products Offered
6.5.5 PharmaZell Recent Development
6.6 Lasa Loboratory
6.6.1 Lasa Loboratory Mesalazine Production Sites and Area Served
6.6.2 Lasa Loboratory Description, Business Overview and Total Revenue
6.6.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Lasa Loboratory Products Offered
6.6.5 Lasa Loboratory Recent Development
6.7 Erregierre SpA
6.6.1 Erregierre SpA Mesalazine Production Sites and Area Served
6.6.2 Erregierre SpA Description, Business Overview and Total Revenue
6.6.3 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Erregierre SpA Products Offered
6.7.5 Erregierre SpA Recent Development
6.8 Corden Pharma Bergamo
6.8.1 Corden Pharma Bergamo Mesalazine Production Sites and Area Served
6.8.2 Corden Pharma Bergamo Description, Business Overview and Total Revenue
6.8.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Corden Pharma Bergamo Products Offered
6.8.5 Corden Pharma Bergamo Recent Development
6.9 CTX Lifescience
6.9.1 CTX Lifescience Mesalazine Production Sites and Area Served
6.9.2 CTX Lifescience Description, Business Overview and Total Revenue
6.9.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 CTX Lifescience Products Offered
6.9.5 CTX Lifescience Recent Development
6.10 Ishita Active Pharma Ingredients
6.10.1 Ishita Active Pharma Ingredients Mesalazine Production Sites and Area Served
6.10.2 Ishita Active Pharma Ingredients Description, Business Overview and Total Revenue
6.10.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Ishita Active Pharma Ingredients Products Offered
6.10.5 Ishita Active Pharma Ingredients Recent Development
6.11 YC Biotech (Jiangsu)
6.11.1 YC Biotech (Jiangsu) Mesalazine Production Sites and Area Served
6.11.2 YC Biotech (Jiangsu) Mesalazine Description, Business Overview and Total Revenue
6.11.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 YC Biotech (Jiangsu) Products Offered
6.11.5 YC Biotech (Jiangsu) Recent Development
6.12 Xinxiang Tianfeng Fine Chemical
6.12.1 Xinxiang Tianfeng Fine Chemical Mesalazine Production Sites and Area Served
6.12.2 Xinxiang Tianfeng Fine Chemical Mesalazine Description, Business Overview and Total Revenue
6.12.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Xinxiang Tianfeng Fine Chemical Products Offered
6.12.5 Xinxiang Tianfeng Fine Chemical Recent Development
7 Mesalazine Manufacturing Cost Analysis
7.1 Mesalazine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Mesalazine
7.4 Mesalazine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Mesalazine Distributors List
8.3 Mesalazine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Mesalazine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Mesalazine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Mesalazine by Type (2021-2026)
10.2 Mesalazine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Mesalazine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Mesalazine by Application (2021-2026)
10.3 Mesalazine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Mesalazine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Mesalazine by Region (2021-2026)
10.4 North America Mesalazine Estimates and Projections (2021-2026)
10.5 Europe Mesalazine Estimates and Projections (2021-2026)
10.6 Asia Pacific Mesalazine Estimates and Projections (2021-2026)
10.7 Latin America Mesalazine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Mesalazine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Mesalazine Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Mesalazine Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Mesalazine Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Mesalazine Manufacturers Covered in This Study
Table 5. Global Mesalazine Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Mesalazine Sales Share by Manufacturers (2015-2020)
Table 7. Global Mesalazine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Mesalazine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Mesalazine Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Mesalazine Sales Sites and Area Served
Table 11. Manufacturers Mesalazine Product Types
Table 12. Global Mesalazine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mesalazine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalazine as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Mesalazine Players
Table 16. Global Mesalazine Sales (MT) by Region (2015-2020)
Table 17. Global Mesalazine Sales Market Share by Region (2015-2020)
Table 18. Global Mesalazine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Mesalazine Revenue Market Share by Region (2015-2020)
Table 20. North America Mesalazine Sales by Country (2015-2020) (MT)
Table 21. North America Mesalazine Sales Market Share by Country (2015-2020)
Table 22. North America Mesalazine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Mesalazine Revenue Market Share by Country (2015-2020)
Table 24. Europe Mesalazine Sales by Country (2015-2020) (MT)
Table 25. Europe Mesalazine Sales Market Share by Country (2015-2020)
Table 26. Europe Mesalazine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Mesalazine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Mesalazine Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Mesalazine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Mesalazine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Mesalazine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Mesalazine Sales by Country (2015-2020) (MT)
Table 33. Latin America Mesalazine Sales Market Share by Country (2015-2020)
Table 34. Latin America Mesalazine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Mesalazine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Mesalazine Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Mesalazine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Mesalazine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Mesalazine Revenue Market Share by Country (2015-2020)
Table 40. Global Mesalazine Sales (MT) by Type (2015-2020)
Table 41. Global Mesalazine Sales Share by Type (2015-2020)
Table 42. Global Mesalazine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Mesalazine Revenue Share by Type (2015-2020)
Table 44. Global Mesalazine Price (USD/MT) by Type (2015-2020)
Table 45. Global Mesalazine Sales (MT) by Application (2015-2020)
Table 46. Global Mesalazine Sales Market Share by Application (2015-2020)
Table 47. Global Mesalazine Sales Growth Rate by Application (2015-2020)
Table 48. Syntese A/S Mesalazine Corporation Information
Table 49. Syntese A/S Description and Business Overview
Table 50. Syntese A/S Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Syntese A/S Main Product
Table 52. Syntese A/S Recent Development
Table 53. Divis Laboratories Mesalazine Corporation Information
Table 54. Divis Laboratories Corporation Information
Table 55. Divis Laboratories Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Divis Laboratories Main Product
Table 57. Divis Laboratories Recent Development
Table 58. Cambrex Corporation Mesalazine Corporation Information
Table 59. Cambrex Corporation Corporation Information
Table 60. Cambrex Corporation Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Cambrex Corporation Main Product
Table 62. Cambrex Corporation Recent Development
Table 63. Ipca Laboratories Mesalazine Corporation Information
Table 64. Ipca Laboratories Corporation Information
Table 65. Ipca Laboratories Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Ipca Laboratories Main Product
Table 67. Ipca Laboratories Recent Development
Table 68. PharmaZell Mesalazine Corporation Information
Table 69. PharmaZell Corporation Information
Table 70. PharmaZell Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. PharmaZell Main Product
Table 72. PharmaZell Recent Development
Table 73. Lasa Loboratory Mesalazine Corporation Information
Table 74. Lasa Loboratory Corporation Information
Table 75. Lasa Loboratory Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Lasa Loboratory Main Product
Table 77. Lasa Loboratory Recent Development
Table 78. Erregierre SpA Mesalazine Corporation Information
Table 79. Erregierre SpA Corporation Information
Table 80. Erregierre SpA Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Erregierre SpA Main Product
Table 82. Erregierre SpA Recent Development
Table 83. Corden Pharma Bergamo Mesalazine Corporation Information
Table 84. Corden Pharma Bergamo Corporation Information
Table 85. Corden Pharma Bergamo Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Corden Pharma Bergamo Main Product
Table 87. Corden Pharma Bergamo Recent Development
Table 88. CTX Lifescience Mesalazine Corporation Information
Table 89. CTX Lifescience Corporation Information
Table 90. CTX Lifescience Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. CTX Lifescience Main Product
Table 92. CTX Lifescience Recent Development
Table 93. Ishita Active Pharma Ingredients Mesalazine Corporation Information
Table 94. Ishita Active Pharma Ingredients Corporation Information
Table 95. Ishita Active Pharma Ingredients Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Ishita Active Pharma Ingredients Main Product
Table 97. Ishita Active Pharma Ingredients Recent Development
Table 98. YC Biotech (Jiangsu) Mesalazine Corporation Information
Table 99. YC Biotech (Jiangsu) Corporation Information
Table 100. YC Biotech (Jiangsu) Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. YC Biotech (Jiangsu) Main Product
Table 102. YC Biotech (Jiangsu) Recent Development
Table 103. Xinxiang Tianfeng Fine Chemical Mesalazine Corporation Information
Table 104. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 105. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Xinxiang Tianfeng Fine Chemical Main Product
Table 107. Xinxiang Tianfeng Fine Chemical Recent Development
Table 108. Sales Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Mesalazine Distributors List
Table 111. Mesalazine Customers List
Table 112. Market Key Trends
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Global Mesalazine Sales (MT) Forecast by Type (2021-2026)
Table 116. Global Mesalazine Sales Market Share Forecast by Type (2021-2026)
Table 117. Global Mesalazine Revenue (Million US$) Forecast by Type (2021-2026)
Table 118. Global Mesalazine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 119. Global Mesalazine Sales (MT) Forecast by Application (2021-2026)
Table 120. Global Mesalazine Revenue (Million US$) Forecast by Application (2021-2026)
Table 121. Global Mesalazine Sales (MT) Forecast by Region (2021-2026)
Table 122. Global Mesalazine Sales Market Share Forecast by Region (2021-2026)
Table 123. Global Mesalazine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Global Mesalazine Revenue Market Share Forecast by Region (2021-2026)
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Mesalazine
Figure 2. Global Mesalazine Sales Market Share by Type: 2020 VS 2026
Figure 3. Purity = 97 % Product Picture
Figure 4. Purity = 98 % Product Picture
Figure 5. Purity = 99 % Product Picture
Figure 6. Global Mesalazine Consumption Market Share by Application: 2020 VS 2026
Figure 7. Mesalazine Tablets
Figure 8. Mesalazine Capsules
Figure 9. Others
Figure 10. Global Mesalazine Market Size 2015-2026 (US$ Million)
Figure 11. Global Mesalazine Sales Capacity (MT) (2015-2026)
Figure 12. Global Mesalazine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Mesalazine Sales Share by Manufacturers in 2020
Figure 14. Global Mesalazine Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Mesalazine Revenue in 2019
Figure 16. Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Mesalazine Sales Market Share by Region (2015-2020)
Figure 18. Global Mesalazine Sales Market Share by Region in 2019
Figure 19. Global Mesalazine Revenue Market Share by Region (2015-2020)
Figure 20. Global Mesalazine Revenue Market Share by Region in 2019
Figure 21. North America Mesalazine Sales Market Share by Country in 2019
Figure 22. North America Mesalazine Revenue Market Share by Country in 2019
Figure 23. U.S. Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 24. U.S. Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 26. Canada Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Mesalazine Sales Market Share by Country in 2019
Figure 28. Europe Mesalazine Revenue Market Share by Country in 2019
Figure 29. Germany Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 30. Germany Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 32. France Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 34. U.K. Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 36. Italy Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 38. Russia Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Mesalazine Sales Market Share by Region in 2019
Figure 40. Asia Pacific Mesalazine Revenue Market Share by Region in 2019
Figure 41. China Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 42. China Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 44. Japan Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 46. South Korea Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 48. India Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 50. Australia Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 52. Taiwan Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 54. Indonesia Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 56. Thailand Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 58. Malaysia Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 60. Philippines Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 62. Vietnam Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Mesalazine Sales Market Share by Country in 2019
Figure 64. Latin America Mesalazine Revenue Market Share by Country in 2019
Figure 65. Mexico Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 66. Mexico Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 68. Brazil Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 70. Argentina Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Mesalazine Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Mesalazine Revenue Market Share by Country in 2019
Figure 73. Turkey Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 74. Turkey Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 76. Saudi Arabia Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Mesalazine Sales Growth Rate (2015-2020) (MT)
Figure 78. U.A.E Mesalazine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Mesalazine by Type (2015-2020)
Figure 80. Sales Market Share of Mesalazine by Type in 2019
Figure 81. Revenue Share of Mesalazine by Type (2015-2020)
Figure 82. Revenue Market Share of Mesalazine by Type in 2019
Figure 83. Global Mesalazine Sales Growth by Type (2015-2020) (MT)
Figure 84. Global Mesalazine Sales Market Share by Application (2015-2020)
Figure 85. Global Mesalazine Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Mesalazine by Application (2015-2020)
Figure 87. Global Revenue Share of Mesalazine by Application in 2020
Figure 88. Syntese A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Divis Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Cambrex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Ipca Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. PharmaZell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Lasa Loboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Erregierre SpA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Corden Pharma Bergamo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. CTX Lifescience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Ishita Active Pharma Ingredients Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. YC Biotech (Jiangsu) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Xinxiang Tianfeng Fine Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Mesalazine
Figure 102. Manufacturing Process Analysis of Mesalazine
Figure 103. Mesalazine Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Mesalazine Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 108. North America Mesalazine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Mesalazine Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Mesalazine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Mesalazine Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Mesalazine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Mesalazine Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Mesalazine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Mesalazine Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Mesalazine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs